3-(2,2,2-trimethylhydrazine)propionate has been researched along with Infarction, Middle Cerebral Artery in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dambrova, M; Liepinsh, E; Muceniece, R; Pugovics, O; Svalbe, B; Vavers, E; Zvejniece, L | 1 |
1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Infarction, Middle Cerebral Artery
Article | Year |
---|---|
Mildronate treatment improves functional recovery following middle cerebral artery occlusion in rats.
Topics: Adjuvants, Immunologic; Analysis of Variance; Animals; Betaine; Brain Infarction; Carnitine; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Extremities; Infarction, Middle Cerebral Artery; Locomotion; Male; Methylhydrazines; Psychomotor Performance; Rats; Rats, Wistar; Recovery of Function; Rotarod Performance Test; Tandem Mass Spectrometry; Vibrissae | 2011 |